Join Michelle Martin on her tour of markets! Today's discussion covers Eli Lilly's latest drug study results and competition with Novo Nordisk. Learn about JD.com's share price drop, Johnson & Johnson's acquisition, and Lowe's revised outlook. SATS’ return to profitability and StarHub's recent broadband outage are also on the agenda. Plus, discover insights into gold's record highs and China's growing nuclear power investments with Michelle and IG Markets Yeap Jun Rong.

Money and Me: Property on the Blockchain in SG?
17:17

Market View: Amazon vs Walmart, Genting’s Bet & The STI at 5,000
23:38

Money and Me: AI shockwave and SAAS & India’s Early Equity Moment
23:47